Carbetocin versus oxytocin in primigravida for active management of third stage of labor: a prospective study

Authors

  • Ambika Patil Department of Obstetrics and Gynaecology, Al-Ameen Medical College and Hospital, Vijayapur, Karnataka, India
  • Mounika Puram Department of Obstetrics and Gynaecology, Al-Ameen Medical College and Hospital, Vijayapur, Karnataka, India
  • Vidya A. Thobbi Department of Obstetrics and Gynaecology, Al-Ameen Medical College and Hospital, Vijayapur, Karnataka, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20240460

Keywords:

PPH, Active management of third stage of labor, Oxytocin, Carbetocin, Vaginal delivery, Uterotonic agents

Abstract

Background: Postpartum haemorrhage (PPH) stands as a prominent global contributor to maternal mortality. Oxytocin's short half-life and heat sensitivity pose challenges in resource-limited areas. Carbetocin, not requiring cold storage, is utilized in third-stage labor management. Consequently, this study aimed to compare the effectiveness of carbetocin with oxytocin in third-stage labor management.

Methods: In this prospective study of 200 primigravida patients, group A received heat-stable carbetocin (100 μg), while group B received oxytocin (10 IU) postpartum. Primary outcome such as mean blood loss in ml and Secondary outcomes such as proportion with blood loss >500 ml, need for uterotonic agents, blood transfusion, surgical PPH management, and drop in haemoglobin after 48 hours were recorded and compared.

Results: Groups A and B, comparable in age, blood pressure, and mild anaemia, exhibited significant gestational age differences (p<0.0001). Group B had higher mean blood loss (377.68 ml) than group A (345.34 ml) with a significant p=0.0118*. Side effects showed no differences among groups. Postpartum, group B saw a significant 7% incidence of haemorrhage compared to none in group A (p=0.0071).

Conclusions: Carbetocin showed superiority over oxytocin in the active management of third stage of labor, exhibiting a statistically significant reduction in PPH incidence and decreased requirement for additional uterotonic drugs.

References

Blondel B, Coulm B, Bonnet C, Goffinet F, Le Ray C, National Coordination Group of the National Perinatal Surveys. Trends in perinatal health in metropolitan France from 1995 to 2016: Results from the French National Perinatal Surveys. J Gynecol Obstetr Human Reproduct. 2017;46(10):701-13.

Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J et al. Global causes of maternal death: a WHO systematic analysis. Lancet Global Health. 2014;2(6):e323-33.

World Health Organization. WHO recommendations Uterotonics for the prevention of postpartum haemorrhage: Web annex 7: Choice of uterotonic agents. World Health Organization. 2018.

Sentilhes L, Goffinet F, Vayssière C, Deneux‐Tharaux C. Comparison of postpartum haemorrhage guidelines: discrepancies underline our lack of knowledge. Int J Obstetr Gynaecol. 2017;124(5):718-22.

Voon HY, Suharjono HN, Shafie AA, Bujang MA. Carbetocin versus oxytocin for the prevention of postpartum hemorrhage: A meta-analysis of randomized controlled trials in cesarean deliveries. Taiwan J Obstetr Gynecol. 2018;57(3):332-9.

Amornpetchakul P, Lertbunnaphong T, Boriboonhiransarn D, Leetheeragul J, Sirisomboon R, Jiraprasertwong R. Intravenous carbetocin versus intravenous oxytocin for preventing atonic postpartum hemorrhage after normal vaginal delivery in high-risk singleton pregnancies: a triple-blind randomized controlled trial. Arch Gynecol Obstetr. 2018;298:319-27.

Widmer M, Piaggio G, Nguyen TM, Osoti A, Owa OO, Misra S et al. Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth. N Eng J Med. 2018;379(8):743-52.

Maged AM, Hassan AM, Shehata NA. Carbetocin versus oxytocin for prevention of postpartum hemorrhage after vaginal delivery in high risk women. J Maternal-Fetal Neonatal Med. 2016;29(4):532-6.

Van der Nelson H, O'Brien S, Burnard S, Mayer M, Alvarez M, Knowlden J et al. Intramuscular oxytocin versus Syntometrine® versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: a randomised double‐blinded clinical trial of effectiveness, side effects and quality of life. Int J Obstetr Gynaecol. 2021;128(7):1236-46.

Sichitiu J, Baud D, Desseauve D. Carbetocin for the prevention of post-partum hemorrhage after vaginal birth: a real-world application. J Maternal-Fetal Neonatal Med. 2022;35(25):8114-7.

Boucher M, Nimrod CA, Tawagi GF, Meeker TA, White RE, Varin J. Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery: a double-blind randomized trial. J Obstetr Gynaecol Canada. 2004;26(5):481-8.

Reyes OA, Gonzalez GM. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in patients with severe preeclampsia: a double-blind randomized controlled trial. J Obstetr Gynaecol Canada. 2011;33(11):1099-104.

Ashraf F, Akther P, Yasmin N, Islam JA, Akther M, Rahman R et al. Carbetocin versus Oxytocin in Active Management of 3rd stage of Labour following Vaginal Delivery. Biores Communicat. 2021;7(1):927-31.

El Behery MM, El Sayed GA, El Hameed AA, Soliman BS, Abdelsalam WA, Bahaa A. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in obese nulliparous women undergoing emergency cesarean delivery. J Maternal-Fetal Neonatal Med. 2016;29(8):1257-60.

Agnes P, Fenix M, Trinidad RV. Double-Blind Randomized Controlled Trial Comparing the Effect of Carbetocin and Oxytocin for the Prevention of Postpartum Hemorrhage Among High Risk Women Following Vaginal Delivery. Philippine J Obstetr Gynecol. 2011;35(4):169-75.

Ortiz SR, Aguado RP, Hernandez RS, Castorena M. Carbetocin versus oxytocin for prevention of postpartum haemorrhage: a randomised controlled trial. Lancet. 2014;383:51.

Holleboom CA, Van Eyck J, Koenen SV, Kreuwel IA, Bergwerff F, Creutzberg ECet al. Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands. Arch Gynecol Obstetr. 2013;287:1111-7.

Arulkumaran S, Mavrides E, Penney GC. Prevention and management of postpartum haemorrhage. Royal College Obstetricians Gynaecologists Green-top Guideline. 2009;52.

Tunçalp Ö, Souza JP, Gülmezoglu M. New WHO recommendations on prevention and treatment of postpartum hemorrhage. Int J Gynecol Obstetr. 2013;123(3):254-6.

Mavrides E, Allard S, Chandraharan E, Collins P, Green L, Hunt BJ, Riris S, Thomson AJ on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. BJOG. 2016;124:e106-49.

Nederlandse Vereniging van Obstetrie en Gynaecologie. Hemorrhagia postpartum. NVOG richtlijn. 2011. https://www.nvog.nl/wp-content/uploads/2018/02/Hemorrhagia-postpartum-HPP-3.0-14-11-2013.pdf. Accessed on 26 August 2023.

Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta‐analysis. Cochrane Database Systematic Rev. 2018(12):CD011689.

Elsafty MS, Hassanin AS, Laban M, Ibrahim AM, Ahmed WU, Abou Elnoor AA. Intravenous carbetocin shot is superior to oxytocin infusion for placental delivery in second trimester abortion: a pilot randomized controlled trial. J Maternal-Fetal Neonatal Med. 2016;29(5):850-4.

Downloads

Published

2024-02-27

Issue

Section

Original Research Articles